Armata Pharmaceuticals, Inc. Share Price
ARMPArmata Pharmaceuticals, Inc. Stock Performance
Open $6.60 | Prev. Close $6.46 | Circuit Range N/A |
Day Range $6.42 - $6.66 | Year Range $1.95 - $16.34 | Volume 5,611 |
Average Traded $6.57 |
Armata Pharmaceuticals, Inc. Share Price Chart
About Armata Pharmaceuticals, Inc.
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on the development of targeted bacteriophage therapeutics for antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has research collaboration agreement with Merck Sharp & Dohme Corp. for developing synthetic bacteriophage candidates to target undisclosed infectious disease agents. The company is based in Los Angeles, California. Armata Pharmaceuticals, Inc. operates as a subsidiary of Innoviva, Inc.
Armata Pharmaceuticals, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Jun-26 | $6.60 | $6.42 | +0.00% |
30-Jun-26 | $6.60 | $6.42 | -0.47% |
29-Jun-26 | $7.08 | $6.45 | -8.51% |
26-Jun-26 | $6.59 | $7.05 | +6.33% |
25-Jun-26 | $7.53 | $6.63 | -9.49% |
24-Jun-26 | $7.03 | $7.33 | +5.09% |
23-Jun-26 | $6.87 | $6.97 | +1.01% |